Health concerns, changes in lifestyle, job losses, economic hardships, and the death of family members during the Covid-19 pandemic have led to depressive disorders. Here, a 39-year-old man referred to a psychiatric clinic with the complication of depressed mood, which was exacerbated by stress, anxiety, restlessness, and insomnia. In addition, he was referred to a cardiologist and dermatologist because of uncontrolled tachycardia and urticaria. After detailed examination, the final diagnosis was COVID-19, along with anxiety disorder and dermatological diseases. Since the Coronavirus disease (COVID-19) can cause stress and psychological problems, it can disrupt the patient's healing process if ignored. On the other hand, there seems to be a strong association between psychiatric illnesses with COVID-19 and urticaria that can be investigated.
Bidaki, R., Zarnegar, F., & Saghafi, F. (2022). COVID-19 in a Depressed Patient with Generalized Urticaria. Advances in Pharmacology and Therapeutics Journal, 2(1), 4-7. https://doi.org/10.18502/aptj.v2i1.10650
MLA
Bidaki, R., Zarnegar, F., & Saghafi, F. "COVID-19 in a Depressed Patient with Generalized Urticaria", Advances in Pharmacology and Therapeutics Journal, 2, 1, 2022, 4-7. doi: 10.18502/aptj.v2i1.10650
HARVARD
Bidaki R., Zarnegar F., Saghafi F. (2022). 'COVID-19 in a Depressed Patient with Generalized Urticaria', Advances in Pharmacology and Therapeutics Journal, 2(1), pp. 4-7. doi: 10.18502/aptj.v2i1.10650
CHICAGO
R. Bidaki, F. Zarnegar & F. Saghafi, "COVID-19 in a Depressed Patient with Generalized Urticaria," Advances in Pharmacology and Therapeutics Journal, 2 1 (2022): 4-7, doi: 10.18502/aptj.v2i1.10650
VANCOUVER
Bidaki R., Zarnegar F., Saghafi F. COVID-19 in a Depressed Patient with Generalized Urticaria. APTJ. 2022;2(1):4-7. doi: 10.18502/aptj.v2i1.10650
